468 related articles for article (PubMed ID: 16841857)
1. n-3 fatty acids and cardiovascular disease.
Breslow JL
Am J Clin Nutr; 2006 Jun; 83(6 Suppl):1477S-1482S. PubMed ID: 16841857
[TBL] [Abstract][Full Text] [Related]
2. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.
Thies F; Nebe-von-Caron G; Powell JR; Yaqoob P; Newsholme EA; Calder PC
Am J Clin Nutr; 2001 Mar; 73(3):539-48. PubMed ID: 11237929
[TBL] [Abstract][Full Text] [Related]
3. Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids.
Rupp H; Wagner D; Rupp T; Schulte LM; Maisch B
Herz; 2004 Nov; 29(7):673-85. PubMed ID: 15580322
[TBL] [Abstract][Full Text] [Related]
4. U.S. adults are not meeting recommended levels for fish and omega-3 fatty acid intake: results of an analysis using observational data from NHANES 2003-2008.
Papanikolaou Y; Brooks J; Reider C; Fulgoni VL
Nutr J; 2014 Apr; 13():31. PubMed ID: 24694001
[TBL] [Abstract][Full Text] [Related]
5. (n-3) fatty acids and cardiovascular health: are effects of EPA and DHA shared or complementary?
Mozaffarian D; Wu JH
J Nutr; 2012 Mar; 142(3):614S-625S. PubMed ID: 22279134
[TBL] [Abstract][Full Text] [Related]
6. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
Abdelhamid AS; Brown TJ; Brainard JS; Biswas P; Thorpe GC; Moore HJ; Deane KH; Summerbell CD; Worthington HV; Song F; Hooper L
Cochrane Database Syst Rev; 2020 Feb; 3(3):CD003177. PubMed ID: 32114706
[TBL] [Abstract][Full Text] [Related]
7. n-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study.
Lemaitre RN; King IB; Mozaffarian D; Kuller LH; Tracy RP; Siscovick DS
Am J Clin Nutr; 2003 Feb; 77(2):319-25. PubMed ID: 12540389
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 fatty acids and cardiovascular disease.
von Schacky C
Curr Opin Clin Nutr Metab Care; 2007 Mar; 10(2):129-35. PubMed ID: 17284999
[TBL] [Abstract][Full Text] [Related]
9. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
Young GS; Conquer JA; Thomas R
Reprod Nutr Dev; 2005; 45(5):549-58. PubMed ID: 16188207
[TBL] [Abstract][Full Text] [Related]
10. Docosahexaenoic acid (DHA) and cardiovascular disease risk factors.
Holub BJ
Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):199-204. PubMed ID: 19545988
[TBL] [Abstract][Full Text] [Related]
11. Fatty acid facts, Part III: Cardiovascular disease, or, a fish diet is not fishy.
Pauwels EK; Kostkiewicz M
Drug News Perspect; 2008 Dec; 21(10):552-61. PubMed ID: 19221636
[TBL] [Abstract][Full Text] [Related]
12. Omega-3 polyunsaturated fatty acids and cardiovascular diseases.
Lavie CJ; Milani RV; Mehra MR; Ventura HO
J Am Coll Cardiol; 2009 Aug; 54(7):585-94. PubMed ID: 19660687
[TBL] [Abstract][Full Text] [Related]
13. Compared with daily, weekly n-3 PUFA intake affects the incorporation of eicosapentaenoic acid and docosahexaenoic acid into platelets and mononuclear cells in humans.
Browning LM; Walker CG; Mander AP; West AL; Gambell J; Madden J; Calder PC; Jebb SA
J Nutr; 2014 May; 144(5):667-72. PubMed ID: 24647395
[TBL] [Abstract][Full Text] [Related]
14. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
Singh S; Arora RR; Singh M; Khosla S
Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
[TBL] [Abstract][Full Text] [Related]
15. n-3 fatty acids and cardiovascular events after myocardial infarction.
Kromhout D; Giltay EJ; Geleijnse JM;
N Engl J Med; 2010 Nov; 363(21):2015-26. PubMed ID: 20929341
[TBL] [Abstract][Full Text] [Related]
16. Stearidonic acid as a supplemental source of ω-3 polyunsaturated fatty acids to enhance status for improved human health.
Walker CG; Jebb SA; Calder PC
Nutrition; 2013 Feb; 29(2):363-9. PubMed ID: 23102888
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular disease prevention and treatment.
von Schacky C
Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):193-8. PubMed ID: 19520557
[TBL] [Abstract][Full Text] [Related]
18. Influence of three rapeseed oil-rich diets, fortified with alpha-linolenic acid, eicosapentaenoic acid or docosahexaenoic acid on the composition and oxidizability of low-density lipoproteins: results of a controlled study in healthy volunteers.
Egert S; Somoza V; Kannenberg F; Fobker M; Krome K; Erbersdobler HF; Wahrburg U
Eur J Clin Nutr; 2007 Mar; 61(3):314-25. PubMed ID: 16969378
[TBL] [Abstract][Full Text] [Related]
19. Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia.
McKenney JM; Sica D
Pharmacotherapy; 2007 May; 27(5):715-28. PubMed ID: 17461707
[TBL] [Abstract][Full Text] [Related]
20. Marine-derived omega-3 fatty acids: fishing for clues for cancer prevention.
Fabian CJ; Kimler BF
Am Soc Clin Oncol Educ Book; 2013; ():97-101. PubMed ID: 23714467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
